0001871604-21-000002.txt : 20211115 0001871604-21-000002.hdr.sgml : 20211115 20211115161959 ACCESSION NUMBER: 0001871604-21-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211111 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maranian Jeffrey R CENTRAL INDEX KEY: 0001871604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 211410985 MAIL ADDRESS: STREET 1: C/O SUMMIT THERAPEUTICS INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 wf-form4_163701118201148.xml FORM 4 X0306 4 2021-11-11 0 0001599298 Summit Therapeutics Inc. SMMT 0001871604 Maranian Jeffrey R C/O SUMMIT THERAPEUTICS INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 VP Corporate Controller Stock Option (right to buy) 5.28 2021-11-11 4 A 0 50000 A 2031-11-11 Common Stock 50000.0 50000 D The option was granted on November 11, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 11, 2022. Not applicable. /s/ Jeffrey R. Maranian 2021-11-15